EverGlade Consulting Funding Alert: Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program
CHARLESTON, S.C., Nov. 1, 2023 /PRNewswire/ -- The Advanced Research Projects Agency for-Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions according to the scale of their planned projects, categorized into small (BIT/BYTE), medium (KILO/MEGA), and large (GIG/TERA) scales. The REACT program specifically targets the large-scale GIG Module category, aiming to revolutionize therapeutic development and affordability, and enhance patient self-management. The program addresses the issue of ineffective therapeutics, often resulting not from medical unsoundness, but from patient barriers such as limited access and high costs, leading to compromised treatment adherence and poor health outcomes.
- By Laura Powell, Managing Consultant and Eric Jia-Sobota, Founder
CHARLESTON, S.C., Nov. 1, 2023 /PRNewswire/ -- The Advanced Research Projects Agency for-Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. - The REACT program specifically targets the large-scale GIG Module category, aiming to revolutionize therapeutic development and affordability, and enhance patient self-management.
- Living Pharmacy track proposals must address TAs 1-4, and Living Sentinel track proposals must address TAs 1-3 and 5.
- For additional information about EverGlade Consulting, visit: https://www.EverGlade.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/everglade-consulting-funding-al...